ED
SR icon

Exane Derivatives’s Spire SR Stock Holding History

Exane Derivatives’s Portfolio SR Stock Details SR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$196K Buy
+2,639
New +$198K 0.11% 167

Other funds holding SR

American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's SR Position: Q2 2022 in Review

Exane Derivatives opened a new position in Spire (SR) in Q2 2022: 2,639 shares worth $196K. The stake represents 0.11% of the portfolio and ranks #167 among its holdings.

292 funds tracked by Wall St. Rank hold SR as of Q2 2022.

  • Exane Derivatives held 2,639 shares of Spire worth $196K as of Q2 2022.
  • Spire was a new Exane Derivatives position in Q2 2022.
  • Spire made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #167 holding.
  • 292 funds tracked by Wall St. Rank held Spire as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.